In vitro study of virulence potential of Acinetobacter baumannii outer membrane vesicles

Microbial Pathogenesis

Volumn 111, Issue , 2017, Pages 218-224

  Jha, Chandana ^a   Ghosh, Sujata ^a   Gautam, Vikas ^a   Malhotra, Pankaj ^a   Ray, Pallab ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE C; OUTER MEMBRANE PROTEIN; VIRULENCE FACTOR;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; HEMOLYSIS; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANE VESICLE; MORPHOLOGY; NEUTROPHIL; NONHUMAN; PATHOGENICITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; ACINETOBACTER INFECTION; CELL CULTURE; CHEMISTRY; HUMAN; METABOLISM; MICROBIOLOGY; SECRETORY VESICLE; ULTRASTRUCTURE; VIRULENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTERIAL OUTER MEMBRANE PROTEINS; CELLS, CULTURED; HUMANS; SECRETORY VESICLES; TYPE C PHOSPHOLIPASES; VIRULENCE; VIRULENCE FACTORS;

EID: 85028941781     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2017.08.048     Document Type: Article

References (43)

1. Gordon, N.C., Wareham, D.W., Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int. J. Antimicrob. Agents 35 (2010), 219–226.
2. Falagas, M.E., Bliziotis, I.A., Kasiakou, S.K., Samonis, G., Athanassopoulou, P., Michalopoulos, A., Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect. Dis., 5, 2005, 24.
3. Dijkshoorn, L., Nemec, A., Seifert, H., An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5 (2007), 939–951.
4. Asensio, A., Canton, R., Vaque, J., et al. Prevalence of infection by carbapenem-resistant Acinetobacter baumannii in Spain (1999-2005). Enferm. Infecc. Microbiol. Clin. 26 (2008), 199–204.
5. Jun, S.H., Lee, J.H., Kim, B.R., et al. Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins. PLoS One, 8, 2013, e71751.
6. Spellberg, B., Guidos, R., Gilbert, D., et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin. Infect. Dis. 46 (2008), 155–164.
7. Kuehn, M.J., Kesty, N.C., Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19 (2005), 2645–2655.
8. Kadurugamuwa, J.L., Beveridge, T.J., Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 177 (1995), 3998–4008.
9. Mashburn, L.M., Whiteley, M., Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature 437 (2005), 422–425.
10. Lee, E.Y., Choi, D.S., Kim, K.P., Gho, Y.S., Proteomics in gram-negative bacterial outer membrane vesicles. Mass Spectrom. Rev. 27 (2008), 535–555.
11. Ellis, T.N., Kuehn, M.J., Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Mol. Biol. Rev. 74 (2010), 81–94.
12. Yokoyama, K., Horii, T., Yamashino, T., et al. Production of shiga toxin by Escherichia coli measured with reference to the membrane vesicle-associated toxins. FEMS Microbiol. Lett. 192 (2000), 139–144.
13. Keenan, J., Day, T., Neal, S., et al. A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol. Lett. 182 (2000), 259–264.
14. Grandi, G., Bacterial surface proteins and vaccines. F1000 Biol. Rep., 2010, 2.
15. Strasser, A., Kalmar, E., Niedermuller, H., A simple method for the simultaneous separation of peripheral blood mononuclear and polymorphonuclear cells in the dog. Vet. Immunol. Immunopathol. 62 (1998), 29–35.
16. Rainard, P., Corrales, J.C., Barrio, M.B., Cochard, T., Poutrel, B., Leucotoxic activities of Staphylococcus aureus strains isolated from cows, ewes, and goats with mastitis: importance of LukM/LukF'-PV leukotoxin. Clin. Diagn. Lab. Immunol. 10 (2003), 272–277.
17. Morton, R.E., Evans, T.A., Modification of the bicinchoninic acid protein assay to eliminate lipid interference in determining lipoprotein protein content. Anal. Biochem. 204 (1992), 332–334.
18. McConnell, M.J., Rumbo, C., Bou, G., Pachon, J., Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 29 (2011), 5705–5710.
19. Kwon, S.O., Gho, Y.S., Lee, J.C., Kim, S.I., Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol. Lett. 297 (2009), 150–156.
20. Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970), 680–685.
21. Berka, R.M., Gray, G.L., Vasil, M.L., Studies of phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa. Infect. Immun. 34 (1981), 1071–1074.
22. De Silva, N.S., Quinn, P.A., Rapid screening assay for phospholipase C activity in mycoplasmas. J. Clin. Microbiol. 25 (1987), 729–731.
23. Balsalobre, C., Silvan, J.M., Berglund, S., Mizunoe, Y., Uhlin, B.E., Wai, S.N., Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli. Mol. Microbiol. 59 (2006), 99–112.
24. Moon, D.C., Choi, C.H., Lee, J.H., et al. Acinetobacter baumannii outer membrane protein A modulates the biogenesis of outer membrane vesicles. J. Microbiol. 50 (2012), 155–160.
25. Fiocca, R., Necchi, V., Sommi, P., et al. Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium. J. Pathol. 188 (1999), 220–226.
26. Kato, S., Kowashi, Y., Demuth, D.R., Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb. Pathog. 32 (2002), 1–13.
27. Jin, J.S., Kwon, S.O., Moon, D.C., et al. Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS One, 6, 2011, e17027.
28. Rumbo, C., Fernandez-Moreira, E., Merino, M., et al. Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55 (2011), 3084–3090.
29. Liao, Y.T., Kuo, S.C., Chiang, M.H., et al. Acinetobacter baumannii extracellular OXA-58 is primarily and selectively released via outer membrane vesicles after sec-dependent periplasmic translocation. Antimicrob. Agents Chemother. 59 (2015), 7346–7354.
30. Chutkan, H., Macdonald, I., Manning, A., Kuehn, M.J., Quantitative and qualitative preparations of bacterial outer membrane vesicles. Methods Mol. Biol. 966 (2013), 259–272.
31. Koning, R.I., de Breij, A., Oostergetel, G.T., Nibbering, P.H., Koster, A.J., Dijkshoorn, L., Cryo-electron tomography analysis of membrane vesicles from Acinetobacter baumannii ATCC19606 T. Res. Microbiol. 164 (2013), 397–405.
32. Weber, B.S., Kinsella, R.L., Harding, C.M., Feldman, M.F., The secrets of acinetobacter secretion. Trends Microbiol. 25 (2017), 532–545.
33. Li, Z.T., Zhang, R.L., Bi, X.G., et al. Outer membrane vesicles isolated from two clinical Acinetobacter baumannii strains exhibit different toxicity and proteome characteristics. Microb. Pathog. 81 (2015), 46–52.
34. Bergmann, U., Scheffer, J., Koller, M., et al. Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect. Immun. 57 (1989), 2187–2195.
35. Berk, R.S., Brown, D., Coutinho, I., Meyers, D., In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa. Infect. Immun. 55 (1987), 1728–1730.
36. Govan, J.R., Harris, G.S., Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol. Sci. 3 (1986), 302–308.
37. Prevost, G., Mourey, L., Colin, D.A., Menestrina, G., Staphylococcal pore-forming toxins. Curr. Top. Microbiol. Immunol. 257 (2001), 53–83.
38. Kieselbach, T., Zijnge, V., Granstrom, E., Oscarsson, J., Proteomics of aggregatibacter actinomycetemcomitans outer membrane vesicles. PLoS One, 10, 2015, e0138591.
39. Roy-Byrne, P., Russo, J., Dugdale, D.C., Lessler, D., Cowley, D., Katon, W., Undertreatment of panic disorder in primary care: role of patient and physician characteristics. J. Am. Board Fam. Pract. 15 (2002), 443–450.
40. Horstman, A.L., Kuehn, M.J., Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J. Biol. Chem. 275 (2000), 12489–12496.
41. Kesty, N.C., Mason, K.M., Reedy, M., Miller, S.E., Kuehn, M.J., Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 23 (2004), 4538–4549.
42. Kolling, G.L., Matthews, K.R., Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl. Environ. Microbiol. 65 (1999), 1843–1848.
43. Lindmark, B., Rompikuntal, P.K., Vaitkevicius, K., et al. Outer membrane vesicle-mediated release of cytolethal distending toxin (CDT) from Campylobacter jejuni. BMC Microbiol., 9, 2009, 220.